Ben L Da1, Farial Rahman1, Walter C Lai1, David E Kleiner2, Theo Heller1, Christopher Koh1. 1. Liver Diseases Branch, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA. 2. Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Abstract
INTRODUCTION: The American Association for the Study of Liver Diseases recommends hepatitis D virus (HDV) screening in certain high-risk groups; however, the effectiveness is unknown. METHODS: A study of North American patients with hepatitis B (HBV) referred to the NIH was performed to identify risk factors associated with HDV infection. Active HDV was "confirmed" by serum HDV RNA or histologic HDV antigen staining. RESULTS: Six hundred fifty-two were studied, of which 91 were HDV "confirmed." Independent risk factors for HDV included: intravenous drug users, HBV-DNA <2,000 IU/mL, alanine aminotransferase >40 U/L, and HDV endemic country of origin. DISUSSION: North American patients with HBV and significant risk factors should be screened for HDV.
INTRODUCTION: The American Association for the Study of Liver Diseases recommends hepatitis D virus (HDV) screening in certain high-risk groups; however, the effectiveness is unknown. METHODS: A study of North American patients with hepatitis B (HBV) referred to the NIH was performed to identify risk factors associated with HDV infection. Active HDV was "confirmed" by serum HDV RNA or histologic HDV antigen staining. RESULTS: Six hundred fifty-two were studied, of which 91 were HDV "confirmed." Independent risk factors for HDV included: intravenous drug users, HBV-DNA <2,000 IU/mL, alanine aminotransferase >40 U/L, and HDV endemic country of origin. DISUSSION: North American patients with HBV and significant risk factors should be screened for HDV.
Authors: Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong Journal: Hepatology Date: 2018-04 Impact factor: 17.425
Authors: Charles Béguelin; Darius Moradpour; Roland Sahli; Franziska Suter-Riniker; Alexander Lüthi; Matthias Cavassini; Huldrych F Günthard; Manuel Battegay; Enos Bernasconi; Patrick Schmid; Alexandra Calmy; Dominique L Braun; Hansjakob Furrer; Andri Rauch; Gilles Wandeler Journal: J Hepatol Date: 2016-10-14 Impact factor: 25.083
Authors: A Ponzetto; L B Seeff; Z Buskell-Bales; K G Ishak; J H Hoofnagle; H J Zimmerman; R H Purcell; J L Gerin Journal: Hepatology Date: 1984 Nov-Dec Impact factor: 17.425
Authors: Robert G Gish; Debbie Hana Yi; Steve Kane; Margaret Clark; Michael Mangahas; Sumbella Baqai; Mark A Winters; James Proudfoot; Jeffrey S Glenn Journal: J Gastroenterol Hepatol Date: 2013-09 Impact factor: 4.029
Authors: Carla Osiowy; Ken Swidinsky; Sarah Haylock-Jacobs; Matthew D Sadler; Scott Fung; David Wong; Gerald Y Minuk; Karen E Doucette; Philip Wong; Edward Tam; Curtis Cooper; Alnoor Ramji; Mang Ma; Carmine Nudo; Keith Tsoi; Carla S Coffin Journal: JHEP Rep Date: 2022-02-22